Biopartnering Seminar - From Innovation to Cash Flow.

Tuesday, February 24, 2015 - 6:30pm

Guest Speaker: Vera Belaoussoff, H.B.Sc, M.Sc, VP Corporate Development - CellAegies Devices Inc.

Vera Belaoussoff has over 20 years of experience in research and the healthcare industry. She is currently VP, Corporate Development at CellAegis Devices, a Toronto company which develops and commercializes novel, proprietary medical devices for cardioprotection. Prior to joining CellAegis Devices, Ms. Belaoussoff was responsible for pipeline development at YM BioSciences, a development-stage oncology company, where she was responsible for the acquisition of Australian Cytopia Ltd for the JAK inhibitor CYT387, which subsequently resulted in YM BioSciences’ acquisition by US-based Gilead Sciences in 2013.

She has also provided consulting services to the biotechnology industry, with a focus on strategic development and out-licensing. Ms. Belaoussoff was a healthcare analyst for eight years in the financial services industry, most recently on the buy-side with Scotia Cassels Investment Management where she covered the North American healthcare industry. Prior to that, she was a healthcare analyst in the brokerage industry and participated in over $80 million of biotech financing. Ms. Belaoussoff has her M.Sc. (Molecular Biology) from York University in Toronto, and an Honour’s B.Sc. (Genetics) from the University of Manitoba.

Location: Instructional Centre, Room 120, UTM Campus

All welcome! Light refreshments will be served from 6pm to 6:30pm, outside of Room 120 in the Instructional Centre.